[ad_1] An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS Register now for FREE unlimited access to Reuters.com Register […]
Continue Reading
[ad_1] NEW YORK (AP) — Three studies released Friday offered more evidence that COVID-19 vaccines are standing up to the omicron variant, at least among people who received booster shots. They are the first large U.S. studies to look at vaccine protection against omicron, health officials said. The papers echo previous research — including studies […]
Continue Reading
[ad_1] The logo of French-Austrian biotech firm Valneva is seen outside their headquarters in Vienna, Austria, December 16, 2021. REUTERS/Lisi Niesner Register now for FREE unlimited access to Reuters.com Register Jan 19 (Reuters) – French biotech firm Valneva (VLS.PA) said on Wednesday that preliminary studies showed that three doses of its inactivated COVID-19 vaccine candidate […]
Continue Reading